Latest news
Loading news…
Sensidose
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 LowHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. Sollentuna, Stockholms Lan, Sweden Founded 1998 1-10 employees For Profit
Sensidose AB provides personalized drug delivery solutions for patients with chronic conditions.
Sensidose was acquired by Navamedic in 2023 for $7M.
Total Funding
Available in Pro Last Funding
Available in Pro Acquisitions
0
Monthly Visits
Available in Pro Contacts
0
Patents
8
6 trademarks
Company Details
Funding & Financials
Pro- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
Pro- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- Active technologies
- 3
- Patents granted
- 8
- Trademarks
- 6
- Top patent class
- Medical Or Veterinary Science; Hygiene
- IT spend
- $81K
Company Info
- Founded
- 1998
- Employees
- 1-10
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- Founders
- 2
- News articles
- 8
- HQ
- Sollentuna, Stockholms Lan, Sweden
- Region
- European Union (EU), Nordic Countries, Scandinavia
- Exit date
- Mar 29, 2023
Signals & Scores
- Heat score
- Low
- Growth score
- Low
- Trend (7d)
- -0.4
- Trend (30d)
- 3.6
- Trend (90d)
- 3.4
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Recent News related to Sensidose
Loading news…
FAQs about Sensidose
People who checked this page also checked these
Browse the full Acquirezy directory.